An adolescent was recently diagnosed with generalized anxiety disorder (GAD). When discussing the medication treatment plan, the nurse practitioner should inform the adolescent that:

Rationale: A. Benzodiazepines are not first-line for long-term management of GAD in adolescents, and short-term use does not eradicate symptoms; they mainly provide temporary relief. B. Most medications prescribed for GAD, such as SSRIs and certain SNRIs, are nonaddictive and are considered safe for long-term use in adolescents when monitored appropriately. C. SSRIs typically require several weeks (often 4–6) to show therapeutic effects and do not produce immediate results. D. While avoiding alcohol is generally advised with medications, especially in adolescents, the most relevant point is that first-line GAD medications are nonaddictive.